138 related articles for article (PubMed ID: 37657572)
21. Nrf2 represses FGF21 during long-term high-fat diet-induced obesity in mice.
Chartoumpekis DV; Ziros PG; Psyrogiannis AI; Papavassiliou AG; Kyriazopoulou VE; Sykiotis GP; Habeos IG
Diabetes; 2011 Oct; 60(10):2465-73. PubMed ID: 21852674
[TBL] [Abstract][Full Text] [Related]
22. Fibroblast growth factor 21-deficient mice demonstrate impaired adaptation to ketosis.
Badman MK; Koester A; Flier JS; Kharitonenkov A; Maratos-Flier E
Endocrinology; 2009 Nov; 150(11):4931-40. PubMed ID: 19819944
[TBL] [Abstract][Full Text] [Related]
23. Cellular mechanisms by which FGF21 improves insulin sensitivity in male mice.
Camporez JP; Jornayvaz FR; Petersen MC; Pesta D; Guigni BA; Serr J; Zhang D; Kahn M; Samuel VT; Jurczak MJ; Shulman GI
Endocrinology; 2013 Sep; 154(9):3099-109. PubMed ID: 23766126
[TBL] [Abstract][Full Text] [Related]
24. Naringenin prevents obesity, hepatic steatosis, and glucose intolerance in male mice independent of fibroblast growth factor 21.
Assini JM; Mulvihill EE; Burke AC; Sutherland BG; Telford DE; Chhoker SS; Sawyez CG; Drangova M; Adams AC; Kharitonenkov A; Pin CL; Huff MW
Endocrinology; 2015 Jun; 156(6):2087-102. PubMed ID: 25774553
[TBL] [Abstract][Full Text] [Related]
25. Fibroblast growth factor 21 protects against lipotoxicity-induced pancreatic β-cell dysfunction via regulation of AMPK signaling and lipid metabolism.
Xie T; So WY; Li XY; Leung PS
Clin Sci (Lond); 2019 Oct; 133(19):2029-2044. PubMed ID: 31654570
[TBL] [Abstract][Full Text] [Related]
26. Fibroblast Growth Factor 21 (FGF21) Administration Sex-Specifically Affects Blood Insulin Levels and Liver Steatosis in Obese
Makarova E; Kazantseva A; Dubinina A; Denisova E; Jakovleva T; Balybina N; Bgatova N; Baranov K; Bazhan N
Cells; 2021 Dec; 10(12):. PubMed ID: 34943946
[TBL] [Abstract][Full Text] [Related]
27. Whey protein isolate inhibits hepatic FGF21 production, which precedes weight gain, hyperinsulinemia and hyperglycemia in mice fed a high-fat diet.
Nonogaki K; Kaji T
Sci Rep; 2020 Sep; 10(1):15784. PubMed ID: 32978487
[TBL] [Abstract][Full Text] [Related]
28. Increased fibroblast growth factor 21 expression in high-fat diet-sensitive non-human primates (Macaca mulatta).
Nygaard EB; Møller CL; Kievit P; Grove KL; Andersen B
Int J Obes (Lond); 2014 Feb; 38(2):183-91. PubMed ID: 23736354
[TBL] [Abstract][Full Text] [Related]
29. Fibroblast Growth Factor 21 Mediates Glycemic Regulation by Hepatic JNK.
Vernia S; Cavanagh-Kyros J; Barrett T; Tournier C; Davis RJ
Cell Rep; 2016 Mar; 14(10):2273-80. PubMed ID: 26947074
[TBL] [Abstract][Full Text] [Related]
30. Cholic Acid Supplementation of a High-Fat Obesogenic Diet Suppresses Hepatic Triacylglycerol Accumulation in Mice via a Fibroblast Growth Factor 21-Dependent Mechanism.
Ippagunta SM; Kharitonenkov A; Adams AC; Hillgartner FB
J Nutr; 2018 Apr; 148(4):510-517. PubMed ID: 29659970
[TBL] [Abstract][Full Text] [Related]
31. Fgf21 impairs adipocyte insulin sensitivity in mice fed a low-carbohydrate, high-fat ketogenic diet.
Murata Y; Nishio K; Mochiyama T; Konishi M; Shimada M; Ohta H; Itoh N
PLoS One; 2013; 8(7):e69330. PubMed ID: 23874946
[TBL] [Abstract][Full Text] [Related]
32. Fibroblast growth factor 21 regulates lipolysis in white adipose tissue but is not required for ketogenesis and triglyceride clearance in liver.
Hotta Y; Nakamura H; Konishi M; Murata Y; Takagi H; Matsumura S; Inoue K; Fushiki T; Itoh N
Endocrinology; 2009 Oct; 150(10):4625-33. PubMed ID: 19589869
[TBL] [Abstract][Full Text] [Related]
33. Low-protein diet induces, whereas high-protein diet reduces hepatic FGF21 production in mice, but glucose and not amino acids up-regulate FGF21 in cultured hepatocytes.
Chalvon-Demersay T; Even PC; Tomé D; Chaumontet C; Piedcoq J; Gaudichon C; Azzout-Marniche D
J Nutr Biochem; 2016 Oct; 36():60-67. PubMed ID: 27574977
[TBL] [Abstract][Full Text] [Related]
34. Fibroblast growth factor 21 as an emerging metabolic regulator: clinical perspectives.
Woo YC; Xu A; Wang Y; Lam KS
Clin Endocrinol (Oxf); 2013 Apr; 78(4):489-96. PubMed ID: 23134073
[TBL] [Abstract][Full Text] [Related]
35. FGF21 Signals Protein Status to the Brain and Adaptively Regulates Food Choice and Metabolism.
Hill CM; Laeger T; Dehner M; Albarado DC; Clarke B; Wanders D; Burke SJ; Collier JJ; Qualls-Creekmore E; Solon-Biet SM; Simpson SJ; Berthoud HR; Münzberg H; Morrison CD
Cell Rep; 2019 Jun; 27(10):2934-2947.e3. PubMed ID: 31167139
[TBL] [Abstract][Full Text] [Related]
36. Rapid increase in fibroblast growth factor 21 in protein malnutrition and its impact on growth and lipid metabolism.
Ozaki Y; Saito K; Nakazawa K; Konishi M; Itoh N; Hakuno F; Takahashi S; Kato H; Takenaka A
Br J Nutr; 2015 Nov; 114(9):1410-8. PubMed ID: 26330054
[TBL] [Abstract][Full Text] [Related]
37. Long-term adjustment of hepatic lipid metabolism after chronic stress and the role of FGF21.
Dille M; Nikolic A; Wahlers N; Fahlbusch P; Jacob S; Hartwig S; Lehr S; Kabra D; Klymenko O; Al-Hasani H; Kotzka J; Knebel B
Biochim Biophys Acta Mol Basis Dis; 2022 Jan; 1868(1):166286. PubMed ID: 34624498
[TBL] [Abstract][Full Text] [Related]
38. Fibroblast growth factor 21 (FGF21) is robustly induced by ethanol and has a protective role in ethanol associated liver injury.
Desai BN; Singhal G; Watanabe M; Stevanovic D; Lundasen T; Fisher FM; Mather ML; Vardeh HG; Douris N; Adams AC; Nasser IA; FitzGerald GA; Flier JS; Skarke C; Maratos-Flier E
Mol Metab; 2017 Nov; 6(11):1395-1406. PubMed ID: 29107287
[TBL] [Abstract][Full Text] [Related]
39. Chronic high-sucrose diet increases fibroblast growth factor 21 production and energy expenditure in mice.
Maekawa R; Seino Y; Ogata H; Murase M; Iida A; Hosokawa K; Joo E; Harada N; Tsunekawa S; Hamada Y; Oiso Y; Inagaki N; Hayashi Y; Arima H
J Nutr Biochem; 2017 Nov; 49():71-79. PubMed ID: 28886439
[TBL] [Abstract][Full Text] [Related]
40. Fibroblast growth factor 21 increases hepatic oxidative capacity but not physical activity or energy expenditure in hepatic peroxisome proliferator-activated receptor γ coactivator-1α-deficient mice.
Fletcher JA; Linden MA; Sheldon RD; Meers GM; Morris EM; Butterfield A; Perfield JW; Rector RS; Thyfault JP
Exp Physiol; 2018 Mar; 103(3):408-418. PubMed ID: 29215172
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
